CONTACT US

News & Events

The latest headlines, conversations, and gatherings from Ideogen.

What Are Managed Access Programmes? Definitions and Roles
Featured News

What Are Managed Access Programmes? Definitions and Roles

What a managed access programme is, how it differs from trials and expanded access, and the roles of sponsors, physicians and regulators in the EU and US.

Read More

Latest News

Key Differences: Managed Access, Expanded Access and Clinical Trials

Key Differences: Managed Access, Expanded Access and Clinical Trials

How managed access, expanded access and clinical trials differ in purpose, legal basis, eligibility, data collection and cost, and how to choose a pathway.

Press

BioSpace

BioSpace republished Ayrmid's announcement appointing IDEOGEN as exclusive Omisirge partner across Europe, MENA and CIS, September 2026.
PR Newswire

PR Newswire’s UK edition carried IDEOGEN’s 21 January 2022 announcement on its takeover of the BELEODAQ (belinostat) special access program.
PR Newswire

Emmaus Life Sciences announced its Swissmedic application for Endari, with IDEOGEN A.G. managing the Swiss early-access program, June 2021.
Access Newswire

Read the original September 2026 release: Ayrmid appoints IDEOGEN as exclusive Omisirge partner across 55 markets in Europe, MENA and CIS.
China Monkey Network

Read IDEOGEN’s announcement on taking over the BELEODAQ (belinostat) special access program, republished by China Money Network.
Europa Press

Read the IDEOGEN announcement republished by Europa Press on 24 January 2022 about its takeover of the BELEODAQ (belinostat) special access program.

Events

Ideogen at EORTC-CLTG 2027: Advancing Cutaneous Lymphoma Science
Ideogen at EORTC-CLTG 2027: Advancing Cutaneous Lymphoma Science
Bordeaux, France
Ideogen at EBMT 2027: Cell Therapies and Transplantation
11
April
Ideogen at EBMT 2027: Cell Therapies and Transplantation
Rotterdam, Netherlands
Ideogen at EHA2027: Malignant Haematology and Cellular Therapy
10
June
Ideogen at EHA2027: Malignant Haematology and Cellular Therapy
Barcelona, Spain
Ideogen at ICML 2027: The Science of Malignant Lymphoma
15
June
Ideogen at ICML 2027: The Science of Malignant Lymphoma
Lugano, Switzerland

Frequently Asked Questions